H.Res. 1309 · 111th Congress
Expressing the sense of the House of Representatives that there is need for further study of the Functional…
Full title
Expressing the sense of the House of Representatives that there is need for further study of the Functional Gastrointestinal Disorder (FGID) Irritable Bowel Syndrome (IBS).
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 111th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
BaldwinSponsor10 cosponsors · 7 D, 3 R
R
Sensenbrenner
PW
D
Welch
EN
D
Norton
PR
R
Ryan
RG
D
Grijalva
CY
R
Young
DL
D
Loebsack
AB
D
Boyd
DP
D
Price
NL
D
Lowey2 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Calls for the Director of the National Institutes of Health (NIH) to take a leadership role in the search for new treatment options and a cure for Irritable Bowel Syndrome (IBS) by: (1) encouraging the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to implement the research recommendations of the National Commission on Digestive…
What it does: CRS summary · Introduced in House · Apr 29, 2010
Calls for the Director of the National Institutes of Health (NIH) to take a leadership role in the search for new treatment options and a cure for Irritable Bowel Syndrome (IBS) by: (1) encouraging the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to implement the research recommendations of the National Commission on Digestive Diseases; (2) exploring collaborative research opportunities between the NIDDK, the Office of Research on Women's Health, and other NIH Institutes and Centers; and (3) encouraging NIDDK to provide the necessary funding for continued expansion and advancement of the IBS research portfolio and for education with respect to IBS and Functional Gastrointestinal Disorders (FGIDs) through the cosponsorship of workshops and seminars with patient organizations.
Expresses the sense of the House of Representatives that: (1) funding should be increased for basic and clinical biomedical research into IBS and other FGIDs through NIH; (2) the Director of the Food and Drug Administration (FDA) should take a leadership role in ensuring that new IBS treatments are developed and appropriately monitored; and (3) the Department of Defense (DOD) and the Department of Veterans Affairs (VA) should bolster their efforts to study IBS and FGIDs and their association with war trauma.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Expressing the sense of the House of Representatives that there is need for further study of the Functional Gastrointestinal Disorder (FGID) Irritable Bowel Syndrome (IBS).
Latest action (May 6, 2010): Referred to the Subcommittee on Military Personnel.
Policy area: Health · Origin: House · Introduced: Apr 29, 2010
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.